Understanding Your Breast Cancer Journey Starts Here
Receiving a breast cancer diagnosis can be one of life’s most challenging moments, filled with uncertainty and questions about what comes next. At Oracle Genomics, we understand that having clear, accurate information about your specific cancer type is the first step toward developing an effective treatment plan that’s tailored just for you.
What This Test Reveals About Your Cancer
The Immunohistochemistry Breast Cancer Panel 2 is a sophisticated diagnostic tool that examines specific proteins in your breast tissue sample. This isn’t just another test – it’s a roadmap that helps your medical team understand the unique characteristics of your cancer:
- Estrogen Receptors (ER): Determines if your cancer cells have receptors for estrogen, which helps predict if hormone therapy will be effective
- Progesterone Receptors (PR): Identifies progesterone receptors, providing additional information about hormone responsiveness
- Cathepsin D: Assesses this protein marker that can influence cancer progression and treatment response
- Pathologist Review: Includes expert confirmation of malignant cells by our specialist pathologists
Who Should Consider This Important Test
This comprehensive panel is particularly valuable if you:
- Have recently received a breast cancer diagnosis and need biomarker information for treatment planning
- Are experiencing symptoms that require further investigation of breast tissue
- Have a family history of breast cancer and want comprehensive analysis
- Need confirmation of cancer type and characteristics for targeted therapy decisions
- Want to understand if hormone-based treatments might be effective for your specific cancer
Why This Information Matters for Your Health Journey
Knowing your cancer’s specific biomarkers isn’t just about getting a diagnosis – it’s about getting the right treatment from the start. This test helps:
- Personalize Your Treatment: Avoid one-size-fits-all approaches by identifying therapies that target your specific cancer type
- Reduce Unnecessary Side Effects: Prevent undergoing treatments that may not work for your cancer characteristics
- Improve Treatment Outcomes: Start with the most appropriate therapy based on scientific evidence
- Provide Peace of Mind: Make informed decisions with confidence about your treatment path
Understanding Your Results with Confidence
When your results are ready (typically within 5-7 days), they’ll provide clear information about:
- Whether your cancer is hormone receptor-positive or negative
- The specific levels of ER, PR, and Cathepsin D detected
- Pathologist confirmation of malignant cell presence
- Clear interpretation that your oncologist can use for treatment planning
Remember, these results are one piece of your comprehensive care plan. Your healthcare team will discuss what they mean for your specific situation and how they influence your treatment options.
Transparent Pricing That Puts Your Health First
| Service | Regular Price | Special Price |
|---|---|---|
| Immunohistochemistry Breast Cancer Panel 2 | R2,000 |
Considering that this test can help determine treatments costing thousands of rands, the R2,000 investment provides exceptional value in guiding your healthcare decisions.
Nationwide Access to Quality Cancer Care
Whether you’re in Johannesburg, Cape Town, Durban, Pretoria, or anywhere across South Africa, we’re committed to making advanced cancer diagnostics accessible. Our network ensures that quality testing is available when and where you need it.
Take the Next Step in Your Health Journey
Don’t let uncertainty about your cancer type delay your treatment planning. With rapid 5-7 day turnaround times and comprehensive biomarker analysis, this test provides the clarity you need to move forward with confidence.
Book your test today and take control of your cancer journey with the precise information needed for targeted, effective treatment.
Our team of oncology specialists and pathologists are dedicated to providing accurate, reliable results that you and your healthcare team can trust. Your journey to better understanding and managing your breast cancer starts with one simple test.
